Search by Drug Name or NDC
NDC 71399-8237-08 SENNA 417.12 mg/237mL Details
SENNA 417.12 mg/237mL
SENNA is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Akron Pharma Inc.. The primary component is SENNOSIDES A AND B.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 71399-8237-08Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 71399-8237 |
|---|---|
| Product ID | 71399-8237_d24f7b42-94ba-4f56-864b-b423cf1e5efe |
| Associated GPIs | 46200060201220 |
| GCN Sequence Number | 002922 |
| GCN Sequence Number Description | sennosides SYRUP 8.8MG/5ML ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 08660 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Generic |
| Proprietary Name | SENNA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SENNA |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SYRUP |
| Route | ORAL |
| Active Ingredient Strength | 417.12 |
| Active Ingredient Units | mg/237mL |
| Substance Name | SENNOSIDES A AND B |
| Labeler Name | Akron Pharma Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71399-8237-08 (71399823708)
| NDC Package Code | 71399-8237-8 |
|---|---|
| Billing NDC | 71399823708 |
| Package | 237 mL in 1 BOTTLE (71399-8237-8) |
| Marketing Start Date | 2019-10-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |